CAS: 2401-21-0; 1,2-Dichloro-3-Iodobenzene

该化合物是一种卤化芳香化合物,其分子式为C6H3Cl2I. 这种有机卤化物的特点是苯环上存在两个氯原子和一个碘原子,使其成为有机合成的多用途中间体.它独特的替代模式允许在交叉反应中选择性地发挥功能,如铃木或松冈竹草交织,在那里,碘会起到反应作用.该化合物在制药和农用化学研究中特别有助于构建复杂的芳香框架.在标准条件下和定义明确的再活性特征下,它的稳定使得它成为精确合成的可靠试剂.

结构式图片

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    邻二氯苯置于li(2,2,6,6-Tetramethylpiperidide)*al(Ibu)3,碘体系中,用 四氢呋喃,正己烷 用作溶剂,化学反应 6.0H,以72%的收率获得2,3-二氯碘苯
    参考文献:使用铝酸碱区域选择性和化学选择性直接生成官能化芳香铝化合物
    标题:使用铝酸碱区域选择性和化学选择性直接生成官能化芳香铝化合物
    摘要:使用三异丁基(四甲基哌啶基)铝酸盐 (Ibu3Al(Tmp)Li) 通过去质子定向邻位铝化生成官能化芳族铝化合物的区域选择性和化学选择性直接方法,该方法是通过在 Thf 中混合三异丁基铝 (Ibu3Al) 和四甲基哌啶锂 (Ltmp) 制备的,已经被开发出来.使用 Ibu3Al(Tmp)Li 对各种官能化苯进行去质子铝化,证明可有效直接生成各种邻位官能化铝芳香族和杂芳香族衍生物,尤其是具有亲电子官能团(如氰基,酰胺和卤素)的那些.直接铝化,然后进行亲电捕获(使用 I2),为 1,2-或 1,2,3-多取代芳族化合物提供了一种方便的制备方法.
    Doi:10.1021/ja0473236

    海关参考信息

    专利信息


    专利号:US-6528642-B1
    优先权日:1997-08-29
    标题:Mono-and di-derivatives of cyclodextrins, synthesis thereof and purification and use thereof in support
    发明人:DUVAL RAPHAEL; LEVEQUE HUBERT
    权利人:INST FRANCAIS DU PETROLE; CHIRALSEP SARL
    摘要:Mono- and di-derivatives of cyclodextrins are completely defined, also a method for their synthesis and purification, functionalised cyclodextrins obtained from these derivatives, and the synthesis of supports comprising these cyclodextrin derivatives. Use of the supports for the preparation or separation of enantiomers, for asymmetric synthesis, for catalysis, for the preparation or separation of geometrical isomers or positional isomers, or for the preparation or separation of organic molecules with a hydrophobic nature is also described.

    专利号:US-6048991-A
    优先权日:1990-11-16
    标题:Preparation of epoxides
    发明人:HAERMELING DIETER
    权利人:BASF AG
    摘要:Alpha-hydroxy-epoxides of alpha-alkoxy-epoxides of the formula IV ##STR1## in which the substituents have the following meanings: R 7 , R 8 , R 9 , R 10 , R 11 are independently hydrogen, C 1 -C 20 -alkyl, C 3 -C 12 -cycloalkyl, C 4 -C 20 -cycloalkylalkyl, C 1 -C 20 -hydroxy-alkyl, a heterocyclic ring, or an aryl or C 7 -C 20 -arylalkyl group optionally substituted by C 1 -C 8 -alkyl, C 1 -C 8 -alkoxy, halogen, C 1 -C 4 -haloalkyl, C 1 -C 4 -halo-alkoxy, phenyl, phenoxy, halophenyl, halophenoxy, carboxy, C 2 -C 8 -alkoxycarbonyl, or cyano, or R 7 and R 8 or R 7 and R 9 or R 7 and R 10 or R 9 and R 10 or R 10 and R 11 together form a (CH 2 ) n group in which n is an integer from 1 to 10 and which may be optionally substituted by C 1 -C 8 -alkyl, C 1 -C 8 -alkoxy, and/or halogen, and n R 12 is hydrogen, C 1 -C 8 -alkyl, or benzyl, n provided that R 10 is not hydrogen, methyl, ethyl, propyl, or cyclohexyl when R 7 , R 8 , R 9 , or R 11 is hydrogen, that R 7 is not methyl when R 8 is methyl or phenyl and R 9 , R 10 , or R 11 is hydrogen, that R 7 is not methyl when R 8 , R 9 , R 10 , or R 11 is hydrogen and R 12 is ethyl, that R 7 is not phenyl or hexyl when R 8 , R 9 , R 10 , or R 11 is hydrogen, that R 9 is not methyl when R 7 , R 8 , R 10 , or R 11 is hydrogen, that R 10 and R 11 are not methyl when R 7 , R 8 , or R 9 is hydrogen, and that R 7 and R 10 do not together form an unsubstituted cycloalkyl when R 8 , R 9 , or R 11 is hydrogen. The epoxides of the above formula serve as intermediates for the synthesis of, inter alia, perfumes, plant protectants and polymers.

    专利号:WO-2004087679-A1
    优先权日:2003-04-01
    标 题 :2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases
    发明人:OBRECHT DANIEL; ERMERT PHILIPP; LUTHER ANATOL; EBERLE MARTIN; BACHMANN FELIX
    权利人:APONETICS AG; OBRECHT DANIEL; ERMERT PHILIPP; LUTHER ANATOL; EBERLE MARTIN; BACHMANN FELIX
    摘要:The invention relates to substituted pyrimidines of formula (I) wherein V represents a bond or CR6R7, W represents a bond, NR8 or oxygen, X represents sulfur, or nitrogen substituted by hydrogen or R5, Y represents -CH2-, -CH2CH2-, -CO- or -CS-, R1 represents unsubstituted or substituted aryl or heteroaryl, and the substituents R2, R3, R4, R5, R6, R7 and R8 have the meanings given in the specification. These compounds are selectively inducing apoptosis in cancer cells and can be used for the treatment of neoplastic and autoimmune diseases. The invention relates also to methods of synthesis of such compounds, to their use as medicaments, to pharmaceutical compositions containing same, and to methods of treatment of neoplastic and autoimmune diseases using such compounds of formula (I) or of pharmaceutical compositions containing same.

    专利号:US-10081610-B2
    优先权日:2014-09-12
    标题 :Efficient and scalable synthesis of 2-(1′h-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs
    发明人:SONG JIASHENG; ZHANG SUOMING; LI GUODONG; YANG LUQUING
    权利人:ARIAGEN INC
    摘要:Methods of synthesizing 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) and structural analogs thereof. The methods include condensation reactions or condensation and oxidation reactions to form the thiazoline or thiazole moiety of ITE or its structural analogs.

    专利号:US-4388310-A
    优先权日:1982-03-01
    标 题:6-Amido-2-S-oxides of substituted 2-organothio-pen-2-em-3-carboxylic acids
    发明人:CHRISTENSEN BURTON G; DININNO FRANK P; MUTHARD DAVID A; RATCLIFFE RONALD W
    权利人:MERCK & CO INC
    摘要:Disclosed are 6-amido-2-S-oxides of substituted 2-organothio-pen-2-em-3-carboxylic acids (I) which are useful as antibiotics and as intermediates in the synthesis of substituted pen-2-em-3-carboxylic acids: I wherein: R1 is H or acyl; R2 is hydrogen or methoxyl; R3 is alkyl having from 1-6 carbon atoms; phenylalkyl having 7-12 carbon atoms; and cycloalkyl having 3-6 carbon atoms; and R4 is hydrogen, a removable protecting group or a pharmaceutically acceptable salt or ester moiety.

    专利号:US-10385010-B1
    优先权日:2018-03-28
    标 题 :Expedient synthesis of oseltamivir and related compounds via direct olefin diazidation-diamidation reaction
    发明人:XU HAO; LI HONGZE; SHEN SHOUJIE; ZHU CHENGLIANG
    权利人:UNIV GEORGIA STATE RES FOUND
    摘要:Disclosed herein are improved methods for the preparation of oseltamivir, and intermediates useful thereto.
    上海予利生物科技股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yurlichem.com
    企业联系电话:021-37285141👤
    📞上海予利生物科技股份有限公司 ⚠️参考联系方式
    联系人:严经理
    电话:021-37285141
    手机:15000957566
    传真:021-37285142
    邮箱:yurlichem@hotmail.com
    通信地址: 上海市金山区秋实路688号F楼208室
    邮编: 201512
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市金山区秋实路688号F楼208室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    科邦特化工(杭州)有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.capot.cn
    企业联系电话:0571-85586718👤
    📞科邦特化工(杭州)有限公司 ⚠️参考联系方式
    联系人:景先生
    电话:0571-85586718
    手机:13336094967(外贸专线);13336195806(内需专线)
    传真:0571-85864795
    邮箱:sales@capot.com
    通信地址: 浙江省杭州市滨江区江陵路88号万轮科技园
    邮编: 310051
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省杭州市滨江区江陵路88号万轮科技园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题: Synthesis Of Oligomeric Neolignans And Their Use Synthèse De Néolignanes Oligomères Et Leurs Applications
    摘要:Compounds Having The Structure Formule (I) And Their Uses Are Described Herein.

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2008).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知